| |
| Issue |
Title |
| |
| Vol 18, No 1 (2025) |
The effectiveness of using artificial intelligence in clinical medicine |
Abstract
PDF (Rus)
|
|
D. I. Korabelnikov, A. I. Lamotkin |
| |
| Vol 18, No 1 (2025) |
Problems of using phenol (hydroxybenzene) and parabens as pharmaceutical stabilizers: analysis using machine learning methods |
Abstract
PDF (Rus)
|
|
I. Yu. Torshin, O. A. Gromova |
| |
| Vol 18, No 1 (2025) |
Trends in the industry of clinical trials |
Abstract
PDF (Rus)
|
|
S. S. Milovanov, V. V. Popov, N. V. Teplova |
| |
| Vol 17, No 4 (2024) |
Biologically active supplements: safety, efficacy, market review |
Abstract
PDF (Rus)
|
|
A. M. Stepanova, А. N. Plutnitskiy, E. V. Gameeva |
| |
| Online First |
Biosensors for measuring nitric oxide NO levels in biosubstrates: a systematic analysis |
Abstract
PDF (Rus)
|
|
I. Yu. Torshin, O. A. Gromova, L. A. Mayorova, A. N. Gromov |
| |
| Vol 17, No 3 (2024) |
Cystatin C: factors affecting diagnostic and prognostic value in acute kidney injury |
Abstract
PDF (Rus)
|
|
M. O. Magomedaliev, D. I. Korabelnikov |
| |
| Vol 17, No 3 (2024) |
Biologically active supplements overview: regulation, market trends, application, and health impact |
Abstract
PDF (Rus)
|
|
A. M. Stepanova, A. N. Plutnitskiy, E. V. Gameeva |
| |
| Vol 17, No 3 (2024) |
Artificial intelligence: basic terms and concepts, the application in healthcare and clinical medicine |
Abstract
PDF (Rus)
|
|
A. I. Lamotkin, D. I. Korabelnikov, I. A. Lamotkin |
| |
| Vol 17, No 3 (2024) |
Review of open libraries for pharmacoeconomic analysis in R environment |
Abstract
PDF (Rus)
|
|
I. A. Lackman, R. I. Sladkov, V. M. Timiryanova |
| |
| Vol 17, No 3 (2024) |
Experience of using Beers criteria in clinical practice (according to Russian literature) |
Abstract
PDF (Rus)
|
|
M. S. Cherniaeva, M. A. Rozhkova, M. V. Kazakova, L. A. Egorova, O. M. Maslennikova, G. S. Lebedev, N. V. Lomakin, D. A. Sychev |
| |
| Vol 17, No 2 (2024) |
Cystatin C: diagnostic and prognostic value in acute kidney injury |
Abstract
PDF (Rus)
|
|
D. I. Korabelnikov, M. O. Magomedaliev |
| |
| Vol 17, No 2 (2024) |
Artificial intelligence in healthcare and medicine: the history of key events, its significance for doctors, the level of development in different countries |
Abstract
PDF (Rus)
|
|
A. I. Lamotkin, D. I. Korabelnikov, I. A. Lamotkin, S. A. Livshitz, E. G. Perevalova |
| |
| Vol 17, No 2 (2024) |
Approaches to determining the cost of laboratory tests |
Abstract
PDF (Rus)
|
|
I. I. Khayrullin, V. V. Omelyanovskiy, R. V. Gostishchev, O. A. Sukhorukikh, S. A. Kovaleva, B. G. Gorodetsky |
| |
| Vol 17, No 1 (2024) |
Compounding pharmacy regulations: experience of the Latvian pharmaceutical market |
Abstract
PDF (Rus)
|
|
D. D. Mamedov, D. S. Yurochkin, D. D. Zelikova, S. E. Erdni-Garyaev, Z. M. Golant, I. A. Narkevich |
| |
| Vol 16, No 4 (2023) |
Legal particularities of AI technology usage in real-world data formation |
Abstract
PDF (Rus)
|
|
V. S. Malichenko, A. O. Gadzhieva, N. I. Platonova, A. Yu. Solovieva-Oposhnyanskaya |
| |
| Vol 16, No 4 (2023) |
Peculiarities of real-world data application for health technology assessment in Asian countries |
Abstract
PDF (Rus)
|
|
B. B. Kondratyeva, F. V. Gorkavenko, V. V. Omelyanovskiy |
| |
| Vol 16, No 4 (2023) |
DMOADs and DMARDs in the treatment of patients with joint and spine diseases |
Abstract
PDF (Rus)
PDF (Eng)
|
|
O. A. Shavlovskaya |
| |
| Vol 16, No 4 (2023) |
Oncoprotective effects of chondroprotectors: glucosamine, chondroitin sulfate and undenatured type II collagen |
Abstract
PDF (Rus)
|
|
I. Yu. Torshin, A. G. Chuchalin, O. A. Gromova |
| |
| Vol 16, No 3 (2023) |
The prospects for the use of vitamin B12 derivatives in pharmacology |
Abstract
PDF (Rus)
|
|
I. Yu. Torshin, O. A. Gromova, L. A. Maiorova |
| |
| Vol 16, No 3 (2023) |
Possibilities of using coenzyme Q10 for the treatment of diseases associated with mitochondrial dysfunction and chronic inflammation |
Abstract
PDF (Rus)
|
|
O. A. Gromova, I. Yu. Torshin, A. N. Gromov |
| |
| Vol 16, No 3 (2023) |
Disease-modifying osteoarthritis drugs (DMOADs): new trends in osteoarthritis therapy |
Abstract
PDF (Rus)
|
|
O. A. Shavlovskaya, О. А. Gromova, A. Yu. Kochish, Yu. D. Yukhnovskaya, I. D. Romanov, I. A. Bokova |
| |
| Vol 16, No 2 (2023) |
Key principles of drug therapy in patients with chronic myeloid leukemia |
Abstract
PDF (Rus)
|
|
A. V. Zhuravlev, O. I. Knysh |
| |
| Vol 16, No 2 (2023) |
Molecular pharmacology of coenzyme Q10 in the context of treatment of hyperlipidemic conditions |
Abstract
PDF (Rus)
|
|
O. A. Gromova, I. Yu. Torshin |
| |
| Vol 16, No 2 (2023) |
Real-world data: principles of use in decision making and in health technology assessment |
Abstract
PDF (Rus)
|
|
V. V. Omelyanovskiy, F. V. Gorkavenko, N. V. Ignatyeva, P. A. Mukhortova, O. R. Ryzhova, T. S. Teptsova, A. A. Kingshott, B. B. Kondratyeva |
| |
| Vol 16, No 2 (2023) |
Strengthening rehabilitation for patients with ovarian tumors: current approaches and future directions |
Abstract
PDF (Rus)
|
|
D. V. Blinov, A. G. Solopova, E. E. Achkasov, A. Yu. Vlasina, S. A. Akavova, V. N. Galkin, D. A. Petrenko, G. К. Bykovshchenko |
| |
| Vol 16, No 2 (2023) |
From misconceptions to reasonable osteoarthritis patients therapy |
Abstract
PDF (Rus)
|
|
O. A. Shavlovskaya, О. А. Gromova, I. Yu. Torshin, I. D. Romanov |
| |
| Vol 16, No 2 (2023) |
New pharmacotherapeutic approaches for the treatment of peripheral T-cell lymphoma |
Abstract
PDF (Rus)
|
|
M. А. Sorokina, A. V. Rakhteenko, T. R. Grishina |
| |
| Vol 16, No 1 (2023) |
Compounding pharmacy regulations: experience of the North American pharmaceutical market |
Abstract
PDF (Rus)
|
|
D. D. Mamedov, D. S. Yurochkin, A. A. Leshkevich, S. E. Erdni-Garyaev, Z. M. Golant, I. A. Narkevich |
| |
| Vol 16, No 1 (2023) |
Modern biomarkers of acute kidney injury |
Abstract
PDF (Rus)
|
|
D. I. Korabelnikov, M. O. Magomedaliev |
| |
| Vol 16, No 1 (2023) |
Non-invasive respiratory support in patients with severe community-acquired pneumonia |
Abstract
PDF (Rus)
|
|
S. V. Korotchenko, D. I. Korabelnikov |
| |
| Vol 16, No 1 (2023) |
Systematic computer analysis of the pharmacology of bioflavonoids in the context of increasing the body's antiviral defenses |
Abstract
PDF (Rus)
|
|
O. A. Gromova, I. Yu. Torshin, A. G. Chuchalin |
| |
| Vol 16, No 1 (2023) |
Prospects for using high-throughput sequencing methods to identify new biomarkers of response and resistance to antitumor therapy |
Abstract
PDF (Rus)
|
|
M. А. Sorokina, T. R. Grishina |
| |
| Vol 15, No 4 (2022) |
Possibilities of physical therapy and electrophysical modalities in the complex therapy of pneumonia |
Abstract
PDF (Rus)
|
|
D. I. Korabelnikov, V. V. Grigoryev, О. V. Efimova |
| |
| Vol 15, No 4 (2022) |
Historical milestones of the invention and use of placebo |
Abstract
PDF (Rus)
|
|
A. N. Koterov |
| |
| Vol 15, No 3 (2022) |
Review of international practice of health care provider network planning |
Abstract
PDF (Rus)
|
|
V. V. Omelyanovskiy, D. V. Lukyantseva, N. N. Sisigina |
| |
| Vol 15, No 3 (2022) |
Economic aspects of using new chemotherapy regimens for multidrug and extensively drugresistant tuberculosis |
Abstract
PDF (Rus)
|
|
А. V. Kukurika |
| |
| Vol 15, No 3 (2022) |
The role of real world data and real world evidence in health technology assessment |
Abstract
PDF (Rus)
|
|
E. A. Novoderezhkina, S. К. Zyryanov |
| |
| Vol 15, No 3 (2022) |
Prospects for the use of chondroitin sulfate and glucosamine sulfate in the treatment of patients with obesity-associated osteoarthritis (metabolic syndrome) |
Abstract
PDF (Rus)
|
|
I. Yu. Torshin, О. A. Gromova, A. M. Lila |
| |
| Vol 15, No 3 (2022) |
Economic burden of the novel coronavirus infection: a systematic review |
Abstract
PDF (Rus)
|
|
V. M. Timiryanova, I. A. Lakman, N. Sh. Zagidullin, D. F. Gareeva |
| |
| Vol 15, No 2 (2022) |
Pharmacotherapy of insomnia in childhood |
Abstract
PDF (Rus)
|
|
Z. G. Tadtaeva, A. N. Galustyan, V. V. Rusanovsky, O. A. Gromova, I. S. Sardaryan, M. Yu. Krivdina, N. A. Kuritsyna |
| |
| Vol 15, No 2 (2022) |
Epigenetic aspects in rehabilitation of female cancer patients |
Abstract
PDF (Rus)
|
|
A. G. Solopova, D. V. Blinov, S. V. Demyanov, G. V. Demyanov, E. E. Achkasov, A. Yu. Vlasina, L. N. Sandzhieva, D. M. Ampilogova |
| |
| Vol 15, No 1 (2022) |
The real practice of clinical and economic research of drugs included in the Federal Program of High-Cost Nosologies |
Abstract
PDF (Rus)
|
|
A. S. Kolbin, Yu. M. Gomon, A. R. Kasimova, A. A. Kurylev, A. E. Bem |
| |
| Vol 15, No 1 (2022) |
Strengthening health care to provide rehabilitation services for women with cancer diseases of the reproductive system |
Abstract
PDF (Rus)
|
|
D. V. Blinov, A. G. Solopova, A. N. Plutnitskiy, D. M. Ampilogova, L. N. Sandzhieva, D. I. Korabel’nikov, D. A. Petrenko |
| |
| Vol 15, No 1 (2022) |
Efficacy of targeted drugs for the treatment of adults with moderate-to-severe plaque psoriasis in the Russian Federation: a systematic literature review update |
Abstract
PDF (Rus)
|
|
V. D. Sokolova, N. A. Sableva, V. V. Mladov, D. G. Tolkacheva |
| |
| Vol 15, No 1 (2022) |
A systematic review of real-world clinical practice data in COVID-19: non-interventional studies |
Abstract
PDF (Rus)
|
|
S. A. Mishinova, Yu. M. Gomon, A. S. Kolbin, V. V. Strizheletsky, I. G. Ivanov |
| |
| Vol 15, No 1 (2022) |
Perioperative pharmacotherapy for endoprosthetics: potential of chondroitin sulfate and glucosamine sulfate |
Abstract
PDF (Rus)
|
|
I. Yu. Torshin, T. B. Minasov, N. V. Zagorodniy, A. M. Lila, O. A. Gromova |
| |
| Vol 15, No 1 (2022) |
Application of chondroprotective agents to inhibit osteodestructive processes in the subchondral bone in patients with osteoarthritis |
Abstract
PDF (Eng)
|
|
О. А. Gromova, А. М. Lila, I. Yu. Torshin, I. А. Reier |
| |
| Vol 14, No 4 (2021) |
Prospects of using chondroprotectors for the treatment of pulmonary pathology |
Abstract
PDF (Rus)
|
|
I. Yu. Torshin, O. A. Gromova, A. G. Chuchalin |
| |
| Vol 14, No 4 (2021) |
History of controlled trials in medicine: real priorities are little-known. Report 3. Quasi-randomized and randomized trials in humans and animals |
Abstract
PDF (Rus)
|
|
A. N. Koterov, O. A. Tikhonova, L. N. Ushenkova, A. P. Biryukov |
| |
| Vol 14, No 4 (2021) |
Experience of using telemedicine technologies in healthcare systems of foreign countries and the Russian Federation: systematic review |
Abstract
PDF (Rus)
|
|
O. A. Volkova, S. S. Budarin, E. V. Smirnova, Yu. V. Elbek |
| |
| 1 - 50 of 69 Items |
1 2 > >>
|
